We do consider for early stage clear cell ovarian cancer after surgery and chemotherapy with Canadian data showing a survival advantage with WAR. We, in practice, consider pelvic RT only although these patients are still very infrequently referred by Gyn oncologist http://jco.ascopubs.org/cont...